{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:34:59Z","timestamp":1789824899877,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de Recherche sur le SIDA et les h\u00e9patites (ANRS, France)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.vaccine.2015.08.055","type":"journal-article","created":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T03:52:59Z","timestamp":1440474779000},"page":"5432-5436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Molecular characterization of the 17D-204 yellow fever vaccine"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7985-6132","authenticated-orcid":false,"given":"Maud","family":"Salmona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Gazaignes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Mercier-Delarue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehanara","family":"Korimbocus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Colin de Verdi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"LeGoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Roques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.08.055_bib0175","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/erv.12.6","article-title":"Review of the risks and benefits of yellow fever vaccination including some new analyses","volume":"11","author":"Monath","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0180","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.ento.52.110405.091454","article-title":"Yellow fever: a disease that has yet to be conquered","volume":"52","author":"Barrett","year":"2007","journal-title":"Annu Rev Entomol"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0185","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1001\/jama.1928.02690310005002","article-title":"The transmission of yellow fever to macacus rhesus: preliminary note","volume":"90","author":"Stokes","year":"1928","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0190","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.vaccine.2011.12.057","article-title":"The phylogeny of yellow fever virus 17D vaccines","volume":"30","author":"Stock","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0195","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1016\/j.vaccine.2010.10.070","article-title":"WHO working group on technical specifications for manufacture and evaluation of yellow fever vaccines, Geneva, Switzerland, 13\u201314 May 2009","volume":"28","author":"Ferguson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0200","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1073\/pnas.84.7.2019","article-title":"Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it","volume":"84","author":"Hahn","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0205","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1093\/nar\/17.10.3989","article-title":"Nucleotide sequence comparison of the genome of two 17D-204 yellow fever vaccines","volume":"17","author":"Dupuy","year":"1989","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0210","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.vaccine.2011.09.114","article-title":"Flaviviruses and flavivirus vaccines","volume":"30","author":"Heinz","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0215","first-page":"989","article-title":"Adverse events associated with 17D-derived yellow fever vaccination \u2013 United States, 2001\u20132002","volume":"51","author":"Centers for Disease Control and Prevention (CDC)","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"23","key":"10.1016\/j.vaccine.2015.08.055_bib0220","first-page":"647","article-title":"Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015","volume":"64","author":"Staples","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0225","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0230","first-page":"131","article-title":"Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection","volume":"85","author":"Kengsakul","year":"2002","journal-title":"J Med Assoc Thail Chotmaihet Thangphaet"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0235","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.vaccine.2013.01.054","article-title":"Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010","volume":"31","author":"Breugelmans","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/14740330902808086","article-title":"Safety of 17D derived yellow fever vaccines","volume":"8","author":"Domingo","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0245","series-title":"Notes from the field: fatal yellow fever vaccine-associated viscerotropic disease \u2013 Oregon, September 2014 n.d.","year":"2014"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0250","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1009303","article-title":"An inactivated cell-culture vaccine against yellow fever","volume":"364","author":"Monath","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0255","volume":"vol. 999","author":"Sambrook","year":"2001"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0260","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/bioinformatics\/bts199","article-title":"Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data","volume":"28","author":"Kearse","year":"2012","journal-title":"Bioinforma Oxf Engl"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0265","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01731581","article-title":"A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences","volume":"16","author":"Kimura","year":"1980","journal-title":"J Mol Evol"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0270","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/molbev\/msm092","article-title":"MEGA4 Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0","volume":"24","author":"Tamura","year":"2007","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0275","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.vaccine.2006.06.082","article-title":"High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production","volume":"25","author":"Barban","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0280","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.vaccine.2014.05.040","article-title":"Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013 \u2013 recommendations","volume":"33","author":"WHO","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0285","doi-asserted-by":"crossref","first-page":"e1003458","DOI":"10.1371\/journal.ppat.1003458","article-title":"Dissection of antibody specificities induced by yellow fever vaccination","volume":"9","author":"Vratskikh","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0290","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/viro.1998.9057","article-title":"Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice","volume":"244","author":"Ryman","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0295","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1128\/JVI.74.6.2903-2906.2000","article-title":"Interaction of yellow fever virus French neurotropic vaccine strain with monkey brain: characterization of monkey brain membrane receptor escape variants","volume":"74","author":"Ni","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0300","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature04388","article-title":"Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population","volume":"439","author":"Vignuzzi","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0305","first-page":"1","article-title":"RNA virus populations as quasispecies","volume":"176","author":"Holland","year":"1992","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0310","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/infdis\/jit546","article-title":"Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing","volume":"209","author":"Beck","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0315","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1128\/JVI.75.15.6999-7008.2001","article-title":"Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa","volume":"75","author":"Mutebi","year":"2001","journal-title":"J Virol"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2015.08.055_bib0320","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1099\/0022-1317-67-8-1727","article-title":"Subclinical infections in mice resulting from the modulation of a lethal dose of Semliki Forest virus with defective interfering viruses: neurochemical abnormalities in the central nervous system","volume":"67","author":"Barrett","year":"1986","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0325","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1096-9071(200004)60:4<432::AID-JMV11>3.0.CO;2-7","article-title":"Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996\u20131997 dengue-2 outbreak in French Polynesia","volume":"60","author":"Murgue","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0330","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/315215","article-title":"Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity","volume":"181","author":"Vaughn","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0335","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.vaccine.2015.08.055_bib0340","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/viro.2001.1168","article-title":"Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil","volume":"290","author":"Galler","year":"2001","journal-title":"Virology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15011834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15011834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T21:51:02Z","timestamp":1537393862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15011834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":34,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0264410X15011834"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.08.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular characterization of the 17D-204 yellow fever vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.08.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}